Clinical trial
A Safety and Immunogenicity Study of a Zoster Vaccine in Healthy Adults >= 40 Years
NCT04072497 is registered in ClinicalTrials.gov with Shanghai Institute Of Biological Products as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Immunogenicity Study of a Zoster Vaccine in Healthy Adults >= 40 Years
- Lead sponsor
- Shanghai Institute Of Biological Products
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- November 20, 2018
- Completion date
- April 30, 2020
- Enrollment
- 522 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.